This study is now closed to enrollment. To view currently enrolling studies please go to our currently enrolling studies page. For information on additional studies that will open in the future, please visit our upcoming studies page.

Type 2 Diabetes Clinical Trial West Palm Beach | Clinical Study

You may qualify for a clinical research trial.

We are recruiting participants for a clinical research study to determine the safety and effectiveness of an investigational oral medication for the control of blood glucose levels in people with Type 2 Diabetes. To qualify for this study, participants will be: • men or women 18 years of age or older • diagnosed with Type 2 Diabetes • taking basal Insulin alone or in combination with up to 2 oral diabetes medications to control their Type 2 Diabetes Other eligibility criteria also apply. Qualified participants will receive all study medicines and study-related procedures at no cost. You may also be reimbursed for your time and travel. For more information, please call (561) 802-3060, ext. 8046 or complete this form.

*We respect your privacy. All information submitted in this form is transmitted over secure servers, and will be kept strictly confidential. In response to your inquiry, your information will be added to our in-house database and you will be contacted by email and/or phone by a clinical study coordinator to discuss research opportunities available to you.

Metabolic Research Institute’s clinical trials are the fastest and safest ways to find treatments that work and improve people’s health. Whether it’s diabetes, high blood pressure, heart disease, high cholesterol, or a variety of other health issues, clinical research studies provide the medicine of tomorrow… today.

Metabolic Research Institute, Inc. (“MRI”), is a private Clinical Research Company located at 1515 North Flagler Drive, Suite 440, West Palm Beach Florida 33401. Unless otherwise noted, all study-related appointments for qualified clinical participants in any MRI research trial will take place at this address.